Avidity Partners Management’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.8M	Buy	+1,569,300	New	+$12.5M	1.59%	13
2023 Q3	–	Sell	-1,425,000	Closed	-$35M	–	102
2023 Q2	$35M	Sell	1,425,000 -215,200	-13%	-$5.4M	1.22%	35
2023 Q1	$38.2M	Buy	1,640,200 +790,200	+93%	+$20.2M	1.27%	30
2022 Q4	$21.5M	Buy	+850,000	New	+$20.8M	0.5%	49
2022 Q3	–	Sell	-758,211	Closed	-$19.3M	–	107
2022 Q2	$19.3M	Sell	758,211 -21,789	-3%	-$509K	0.44%	39
2022 Q1	$20.1M	Buy	780,000 +80,000	+11%	+$2.37M	0.45%	53
2021 Q4	$29.3M	Buy	700,000 +185,000	+36%	+$7.25M	0.62%	48
2021 Q3	$22.4M	Buy	515,000 +353,000	+218%	+$15.3M	0.57%	52
2021 Q2	$7.66M	Buy	+162,000	New	+$7.37M	0.21%	80
2020 Q3	–	Sell	-620,600	Closed	-$25.4M	–	88
2020 Q2	$25.4M	Buy	+620,600	New	+$20.8M	1.63%	21